NATUS MEDICAL INC (NTUS) Stock Price, Forecast & Analysis

USA • Nasdaq • NASDAQ:NTUS • US6390501038

32.96 USD
+0.03 (+0.09%)
At close: Jul 20, 2022
32.96 USD
0 (0%)
After Hours: 7/20/2022, 8:05:33 PM

NTUS Key Statistics, Chart & Performance

Key Statistics
Market Cap1.14B
Revenue(TTM)478.31M
Net Income(TTM)12.67M
Shares34.58M
Float33.90M
52 Week High33.93
52 Week Low20.9
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)1.26
PE26.16
Fwd PE20.58
Earnings (Next)08-04
IPO2001-07-20
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
NTUS short term performance overview.The bars show the price performance of NTUS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20 30

NTUS long term performance overview.The bars show the price performance of NTUS in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30

The current stock price of NTUS is 32.96 USD. In the past month the price increased by 2.07%. In the past year, price increased by 32.69%.

NATUS MEDICAL INC / NTUS Daily stock chart

NTUS Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to NTUS. When comparing the yearly performance of all stocks, NTUS is one of the better performing stocks in the market, outperforming 93.25% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

NTUS Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to NTUS. While NTUS has a great health rating, its profitability is only average at the moment.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NTUS Financial Highlights

Over the last trailing twelve months NTUS reported a non-GAAP Earnings per Share(EPS) of 1.26. The EPS increased by 147.06% compared to the year before.


Industry RankSector Rank
PM (TTM) 2.65%
ROA 2.23%
ROE 2.94%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%37.5%
Sales Q2Q%4.26%
EPS 1Y (TTM)147.06%
Revenue 1Y (TTM)13.56%

NTUS Forecast & Estimates

For the next year, analysts expect an EPS growth of 22.4% and a revenue growth 5.1% for NTUS


Analysts
Analysts43.33
Price TargetN/A
EPS Next Y22.4%
Revenue Next Year5.1%

NTUS Ownership

Ownership
Inst Owners91.2%
Ins Owners0.64%
Short Float %N/A
Short RatioN/A

NTUS Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABT ABBOTT LABORATORIES19.33189.676B
ISRG INTUITIVE SURGICAL INC49.14168.855B
SYK STRYKER CORP23.7138.597B
BSX BOSTON SCIENTIFIC CORP21.78115.097B
BDX BECTON DICKINSON AND CO13.9858.942B
IDXX IDEXX LABORATORIES INC43.5151.391B
EW EDWARDS LIFESCIENCES CORP26.5945.321B
RMD RESMED INC22.1238.981B
GEHC GE HEALTHCARE TECHNOLOGY16.0637.494B
DXCM DEXCOM INC27.827.258B

About NTUS

Company Profile

NTUS logo image Natus Medical, Inc. provides medical device solutions focuses on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. The company is headquartered in Middleton, Wisconsin and currently employs 1,400 full-time employees. The company went IPO on 2001-07-20. The company provides product solutions for three end markets: Neuro, Newborn Care, and Hearing & Balance. Its Neuro includes products and services that provide diagnostic, therapeutic, and surgical solutions in neurodiagnostic, neurocritical care and neurosurgery. Newborn Care includes products and services for newborn care, including hearing screening, brain monitoring, eye imaging, jaundice management, live video streaming and various disposable newborn care supplies. Hearing & Balance includes products for hearing assessment and diagnostics, and hearing aid fitting, including computer-based audiological, otoneurologic and vestibular instrumentation for hearing care professionals. Its Neuro products and services include Electroencephalography, Electromyography, Polysomnography, Subdural electrodes, and Cranial access kits.

Company Info

NATUS MEDICAL INC

3150 Pleasant View Road

Middleton WISCONSIN 94566 US

CEO: Jonathan A. Kennedy

Employees: 1400

NTUS Company Website

Phone: 16088298500.0

NATUS MEDICAL INC / NTUS FAQ

What does NTUS do?

Natus Medical, Inc. provides medical device solutions focuses on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. The company is headquartered in Middleton, Wisconsin and currently employs 1,400 full-time employees. The company went IPO on 2001-07-20. The company provides product solutions for three end markets: Neuro, Newborn Care, and Hearing & Balance. Its Neuro includes products and services that provide diagnostic, therapeutic, and surgical solutions in neurodiagnostic, neurocritical care and neurosurgery. Newborn Care includes products and services for newborn care, including hearing screening, brain monitoring, eye imaging, jaundice management, live video streaming and various disposable newborn care supplies. Hearing & Balance includes products for hearing assessment and diagnostics, and hearing aid fitting, including computer-based audiological, otoneurologic and vestibular instrumentation for hearing care professionals. Its Neuro products and services include Electroencephalography, Electromyography, Polysomnography, Subdural electrodes, and Cranial access kits.


What is the stock price of NATUS MEDICAL INC today?

The current stock price of NTUS is 32.96 USD. The price increased by 0.09% in the last trading session.


Does NATUS MEDICAL INC pay dividends?

NTUS does not pay a dividend.


How is the ChartMill rating for NATUS MEDICAL INC?

NTUS has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Should I buy NTUS stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NTUS.


What is the market capitalization of NTUS stock?

NATUS MEDICAL INC (NTUS) has a market capitalization of 1.14B USD. This makes NTUS a Small Cap stock.


What is the next earnings date for NTUS stock?

NATUS MEDICAL INC (NTUS) will report earnings on 2022-08-04, after the market close.